Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: UNIVERSITY OF CALIFORNIA, LOS ANGELES
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2019-09-21 to 2023-09-22
Current total value of award: $3195415
Description: THE OVERARCHING OBJECTIVE OF THIS PROPOSAL IS TO DEVELOP A BIOBANK THAT CAN BE LEVERAGED TO CHARACTERIZE THE DURABILITY AND CORRELATES OF VACCINE-INDUCED AND NATURAL IMMUNITY TO EVD AND TO CHARACTERIZE POTENTIAL CORRELATES OF NATURAL IMMUNITY AND CRO